container

Stryker Hip Lawsuits Move Forward in New Jersey, as Court Schedules June Case Management Conference, Bernstein Liebhard LLP Reports

The Firm is representing numerous Stryker hip recall clients whose claims are pending in the New Jersey proceeding.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Free Case Review
Our Firm is representing numerous Stryker hip recall clients whose claims are pending in this litigation. We are pleased to see the proceeding moving forward.

New York, New York (PRWEB) May 31, 2014

The multicounty litigation established in New Jersey’s Bergen County Superior Court for Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) filed in the wake of the 2012 Rejuvenate and ABG II Modular-Neck Hip Stem recall continues to move forward, Bernstein Liebhard LLP reports. According to court documents, the proceeding’s next Case Management Conference will convene on June 23, 2014. The parties have been directed to submit a proposed agenda seven days prior to the conference. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

“Our Firm is representing numerous Stryker hip recall clients whose claims are pending in this litigation. We are pleased to see the proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have allegedly been harmed by Rejuvenate and ABG II hip stems.

Stryker Hip Recall Litigation
Court documents indicate that 1,220 Stryker hip lawsuits have been filed in Bergen County Superior Court on behalf of individuals who allegedly suffered serious complications due to Rejuvenate and ABG II hip stems. The metal hip components were recalled in July 2012, after it became apparent that patients fitted with the devices were experiencing high rates of fretting and corrosion at the modular-neck junction. Stryker hip recall plaintiffs claim that this action is responsible for a variety of disabling complications, including osteolysis, tissue necrosis, and premature failure of the artificial hip.

In addition to the Stryker hip recall claims pending in New Jersey, over 800 complaints involving similar allegations have been filed in a federal multicounty litigation underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

According to the Stryker recall notice, fretting and corrosion of the Rejuvenate and ABG II stems at the modular-neck junction can result in pain, swelling, and adverse local tissue reactions. However, because such symptoms are not always present, Stryker has advised all recipients of the recalled hip components to undergo medical screening, even if they are not experiencing any signs or symptoms of a failing hip implant.*

Individuals who were allegedly harmed by Rejuvenate or ABG II hip stems may be entitled to file their own Stryker hip lawsuit. To learn more about the Stryker hip recall, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*literature.ortho.stryker.com/files/REJUV_COM_23.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.strykerhiprecallclaims.com/
https://plus.google.com/115936073311125306742?rel=author